Inception Return
(7/31/1995)
|
8.76 %
|
|
YTD Return
|
12.64 %
|
|
NAVPS
(11/11/2026)
|
$72.05
|
|
Change
|
$1.57 / 2.22 %
|
|
|
Growth of $10,000
(As of October 31, 2026)
|
|
MER
|
2.05 %
|
|
Assets ($mil)
|
$3,307.67
|
|
Rank (1Yr)
|
530/1338
|
|
Std Dev (3Yr)
|
16.79 %
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
• To provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances. We will not change the fundamental investment objectives of the fund unless we have the consent of a majority of the voting unitholders of the fund to do so.
|
Fund Manager
RBC Global Asset Management Inc.
Portfolio Manager
Rob Cavallo, RBC Global Asset Management Inc.
Marcello Montanari, RBC Global Asset Management Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of September 30, 2026)
|
Sector Allocation
(As of September 30, 2026)
|
Geographic Allocation
(As of September 30, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| NVIDIA Corp | US Equity | Technology | United States | 10.36% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 9.95% |
| Microsoft Corp | US Equity | Technology | United States | 9.70% |
| Apple Inc | US Equity | Technology | United States | 9.17% |
| Meta Platforms Inc Cl A | US Equity | Technology | United States | 4.74% |
| Broadcom Inc | US Equity | Technology | United States | 3.82% |
| Micron Technology Inc | US Equity | Technology | United States | 3.47% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 2.52% |
| Advanced Micro Devices Inc | US Equity | Technology | United States | 2.36% |
| Johnson & Johnson | US Equity | Healthcare | United States | 2.01% |
Performance Data
(As of October 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-7.61
|
0.72
|
9.51
|
12.64
|
9.12
|
24.83
|
14.80
|
17.81
|
|
Benchmark
|
-2.46
|
0.98
|
8.34
|
13.84
|
11.64
|
23.67
|
14.78
|
15.91
|
|
Quartile Ranking
|
4
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
15.03
|
37.19
|
37.42
|
-22.89
|
24.97
|
29.23
|
25.94
|
8.77
|
22.08
|
-0.84
|
|
Benchmark
|
12.28
|
36.01
|
23.32
|
-12.52
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
|
Quartile Ranking
|
1
|
1
|
1
|
4
|
2
|
1
|
2
|
1
|
1
|
4
|